IMPROVING THE PROGNOSTIC VALUE OF DNA FLOW-CYTOMETRY IN METASTATIC MELANOMA BY COMBINING PLOIDY AND S-PHASE FRACTION

被引:2
|
作者
MUHONEN, T
机构
[1] Department of Radiotherapy and Oncology, Helsinki University Central Hospital, Helsinki, SF-00290
关键词
DNA; FLOW CYTOMETRY; MELANOMA; MELANOMA MORTALITY; PLOIDY; S-PHASE FRACTION;
D O I
10.1097/00008390-199211000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic value of cellular DNA content of melanoma metastases was investigated in tumours from 114 consecutive patients referred to the Helsinki University Central Hospital Melanoma Team. Thirty-six percent of the tumours were diploid and 64% aneuploid. For 91 patients the S-phase fraction was calculable. Tumour ploidy and S-phase fraction (SPF) were shown by multivariate Cox model analysis to be independent prognostic variables and major determinants of survival after first recurrence. Patients with either aneuploid or low SPF tumours survived longer than did those with diploid or high SPF tumours. By combining DNA ploidy and SPF, three types of DNA histograms could be defined, associated with favourable, intermediate and poor prognosis. Patients with aneuploid, low SPF metastases showed a median survival of 57 months, whereas the high-risk group with diploid, high SPF metastases survived only 13 months. When ploidy, SPF, age, sex, TNM stage and duration of disease-free survival were analysed as covariates the division of flow cytometry histograms into these three types resulted in the most significant prognostic factor (p<0.001) in the Cox multivariate analysis.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 50 条
  • [1] PROGNOSTIC VALUE OF S-PHASE FRACTION AND DNA PLOIDY IN ORAL-CARCINOMA STUDIED WITH BROMODEOXYURIDINE LABELING INVITRO AND FLOW-CYTOMETRY
    HEMMER, J
    [J]. ONKOLOGIE, 1992, 15 (01): : 36 - 41
  • [2] IMPROVING THE PROGNOSTIC VALUE OF DNA FLOW-CYTOMETRY IN BREAST-CANCER BY COMBINING DNA INDEX AND S-PHASE FRACTION - A PROPOSED CLASSIFICATION OF DNA HISTOGRAMS IN BREAST-CANCER
    KALLIONIEMI, OP
    BLANCO, G
    ALAVAIKKO, M
    HIETANEN, T
    MATTILA, J
    LAUSLAHTI, K
    LEHTINEN, M
    KOIVULA, T
    [J]. CANCER, 1988, 62 (10) : 2183 - 2190
  • [3] AGNORS IN DUCTAL BREAST-CANCER - CORRELATION WITH PLOIDY AND S-PHASE FRACTION BY DNA FLOW-CYTOMETRY
    BORGIANI, L
    COGORNO, P
    OLIVIERO, J
    TOSO, F
    GAMBINI, G
    TUNESI, G
    CANEPA, M
    [J]. EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1994, 38 (02): : 171 - 176
  • [4] Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma
    Martin, G
    Halwani, F
    Shibata, H
    Meterissian, S
    [J]. CANADIAN JOURNAL OF SURGERY, 2000, 43 (01) : 29 - 34
  • [6] PROGNOSTIC-SIGNIFICANCE OF S-PHASE FRACTION AS MEASURED BY DNA FLOW-CYTOMETRY IN GYNECOLOGIC MALIGNANCIES
    STRANG, P
    STENDAHL, U
    TRIBUKAIT, B
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 677 : 354 - 363
  • [7] Prognostic value of ploidy and S-phase fraction by image and flow cytometry in breast carcinoma. A comparative study
    Peiro, G
    Lerma, E
    Climent, MA
    Segui, MA
    Tugues, D
    Alonso, MC
    Prat, J
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 111 - 111
  • [8] FLOW-CYTOMETRY IN PRIMARY BREAST-CANCER - IMPROVING THE PROGNOSTIC VALUE OF THE FRACTION OF CELLS IN THE S-PHASE BY OPTIMAL CATEGORIZATION OF CUTOFF LEVELS
    SIGURDSSON, H
    BALDETORP, B
    BORG, A
    DALBERG, M
    FERNO, M
    KILLANDER, D
    OLSSON, H
    RANSTAM, J
    [J]. BRITISH JOURNAL OF CANCER, 1990, 62 (05) : 786 - 790
  • [9] DNA FLOW-CYTOMETRY OF CANINE MAMMARY-TUMORS - THE RELATIONSHIP OF DNA-PLOIDY AND S-PHASE FRACTION TO CLINICAL AND HISTOLOGICAL FEATURES
    ALENZA, MDP
    RUTTEMAN, GR
    KUIPERSDIJKSHOORN, NJ
    PENA, L
    MONTOYA, A
    CORNELISSE, CJ
    [J]. RESEARCH IN VETERINARY SCIENCE, 1995, 58 (03) : 238 - 243
  • [10] PROGNOSTIC IMPACT OF DNA-PLOIDY AND S-PHASE FRACTION
    KALLIONIEMI, OP
    MATTILA, J
    HIETANEN, T
    PUNNONEN, R
    LEHTINEN, M
    LAUSLAHTI, K
    KOIVULA, T
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1765 - 1765